Assessment

Antiarrhythmic

• Monitor ECG continuously and blood pressure and respiratory status frequently during administration

• Assess degree of numbness of affected part

• Serum electrolyte levels should be monitored periodically during prolonged therapy

» IM administration may cause CPK levels

• Serum lidocaine levels should be monitored periodically during prolonged or high-dose IV therapy. Therapeutic serum lidocaine levels range from 1.5 to 5 mcg/ml

» Signs and symptoms of toxicity include confusion, excitation, blurred or double vision, nausea, vomiting, ringing in ears, tremors, twitching, seizures, difficulty breathing, severe dizziness or fainting, and unusually slow heart rate

» If symptoms of overdose occur, stop infusion and monitor patient closely

LIDOCAINE is a sample topic found in Davis's Drug Guide. All other sections of this record are viewable by clicking on the index in the left column, or by clicking on "Display all Sections" in the "Content Manager".

To find other Davis's Drug Guide topics, please login or purchase a subscription.